Related Articles
NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells
Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ
Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition
miR‑146b‑5p suppresses glioblastoma cell resistance to temozolomide through targeting TRAF6
ACTL6A knockdown inhibits cell migration by suppressing the AKT signaling pathway and enhances the sensitivity of glioma cells to temozolomide